Rigdon GC - Search Results

1

Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.

Norman MH, Rigdon GC, Navas F 3rd, Cooper BR. Norman MH, et al. Among authors: rigdon gc. J Med Chem. 1994 Aug 5;37(16):2552-63. doi: 10.1021/jm00042a008. J Med Chem. 1994. PMID: 7914539

2

Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.

Norman MH, Navas F 3rd, Thompson JB, Rigdon GC. Norman MH, et al. Among authors: rigdon gc. J Med Chem. 1996 Nov 22;39(24):4692-703. doi: 10.1021/jm9603375. J Med Chem. 1996. PMID: 8941382

3

Effect of linking bridge modifications on the antipsychotic profile of some phthalimide and isoindolinone derivatives.

Norman MH, Minick DJ, Rigdon GC. Norman MH, et al. Among authors: rigdon gc. J Med Chem. 1996 Jan 5;39(1):149-57. doi: 10.1021/jm9502201. J Med Chem. 1996. PMID: 8568802

4

Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.

Norman MH, Rigdon GC, Hall WR, Navas F 3rd. Norman MH, et al. Among authors: rigdon gc. J Med Chem. 1996 Mar 1;39(5):1172-88. doi: 10.1021/jm950551d. J Med Chem. 1996. PMID: 8676355

5

Is clozapine selective for the dopamine D4 receptor?

Durcan MJ, Rigdon GC, Norman MH, Morgan PF. Durcan MJ, et al. Among authors: rigdon gc. Life Sci. 1995;57(18):PL275-83. doi: 10.1016/0024-3205(95)02151-8. Life Sci. 1995. PMID: 7475902

6

Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity.

Musso DL, Cochran FR, Kelley JL, McLean EW, Selph JL, Rigdon GC, Orr GF, Davis RG, Cooper BR, Styles VL, Thompson JB, Hall WR. Musso DL, et al. Among authors: rigdon gc. J Med Chem. 2003 Jan 30;46(3):399-408. doi: 10.1021/jm020067s. J Med Chem. 2003. PMID: 12540239

7

Indanylidenes. 2. Design and synthesis of (E)-2-(4-chloro-6-fluoro-1-indanylidene)-N-methylacetamide, a potent antiinflammatory and analgesic agent without centrally acting muscle relaxant activity.

Musso DL, Orr GF, Cochran FR, Kelley JL, Selph JL, Rigdon GC, Cooper BR, Jones ML. Musso DL, et al. Among authors: rigdon gc. J Med Chem. 2003 Jan 30;46(3):409-16. doi: 10.1021/jm020068k. J Med Chem. 2003. PMID: 12540240

8

1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects.

Rigdon GC, Norman MH, Cooper BR, Howard JL, Boncek VM, Faison WL, Nanry KP, Pollard GT. Rigdon GC, et al. Neuropsychopharmacology. 1996 Sep;15(3):231-42. doi: 10.1016/0893-133X(95)00239-A. Neuropsychopharmacology. 1996. PMID: 8873106

9

Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.

Ferris RM, Brieaddy L, Mehta N, Hollingsworth E, Rigdon G, Wang C, Soroko F, Wastila W, Cooper B. Ferris RM, et al. J Pharm Pharmacol. 1995 Sep;47(9):775-81. doi: 10.1111/j.2042-7158.1995.tb06740.x. J Pharm Pharmacol. 1995. PMID: 8583392

10

A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.

Chang KJ, Rigdon GC, Howard JL, McNutt RW. Chang KJ, et al. Among authors: rigdon gc. J Pharmacol Exp Ther. 1993 Nov;267(2):852-7. J Pharmacol Exp Ther. 1993. PMID: 8246159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters